The stock market's secret weapon may be vanishing
AP
Widely unexpected by strategists at the start of 2017, the falling dollar has served as a secret weapon of sorts for stocks this year, helping to prop up earnings growth amid middling economic data and elevated geopolitical risk.
But the gig may soon be up, at least according to findings from Strategas Research Partners.
They point out that as the gap between US and European 10-year yields has stabilized, the dollar has continued to weaken. Since the two measures have historically traded in lockstep, the gap should close, and that convergence could be driven by a strengthening greenback, Strategas says.
"While there is little question that a weaker dollar is a boost for the U.S. and emerging markets, we would caution on getting too excited on the greenback's recent decline," Nicholas Bohnsack, the president and head of quantitative research at Strategas, wrote in a client note.
In fact, the effect of a weaker dollar on foreign sales has already started to diminish, even though the greenback hasn't yet reversed to the upside in any meaningful way, says Strategas.
They specifically highlight the slowing outperformance of S&P 500 companies with high revenues from overseas, relative to their counterparts that don't draw any foreign sales.
The firm even goes as far as to argue that a stronger dollar could still end up being a positive driver for stocks - that is, if the appreciation is caused by a strengthening economy.
The potential dollar reversal that's being signaled would be bad news for hedge funds and other large speculators, who were recently positioned the most bearish in three years on the US dollar, according to weekly data compiled by the Commodity Futures Trading Commission.
Still, if a stronger dollar means an improving economy, as Strategas suggests, that would be broadly better for US markets in the long run.
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Audi to hike vehicle prices by up to 2% from June
- Kotak Mahindra Bank shares tank 13%; mcap erodes by ₹37,721 crore post RBI action
- Rupee falls 6 paise to 83.39 against US dollar in early trade
- Markets decline in early trade; Kotak Mahindra Bank tanks over 12%
- An Ambani disruption in OTT: At just ₹1 per day, you can now enjoy ad-free content on JioCinema